Related Experiment Video
Updated: May 17, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Inflammatory dilated cardiomyopathy in Abcg5-deficient mice
Dennis W Wilson1, Karen L Oslund, Bonnie Lyons
1Department of Pathology Microbiology and Immunology, School of Veterinary Medicine, University of California-Davis, CA 95616, USA. dwwilson@ucdavis.edu
Toxicologic Pathology
|November 7, 2012
Summary
The Abcg5 gene mutation causes dilated cardiomyopathy (DCM) in mice, linked to plant sterol accumulation. Phytosterol-free diets prevent DCM, suggesting a novel inflammatory cardiomyopathy model.
Area of Science:
- Cardiovascular Biology
- Genetics
- Immunology
Background:
- Dilated cardiomyopathy (DCM) in A/J mice is linked to the Abcg5 gene mutation (trac).
- Human Abcg5 mutations cause sitosterolemia, hypercholesterolemia, and atherosclerosis.
- The trac mutation leads to inflammation, myocyte degeneration, and fibrosis in mouse hearts.
Purpose of the Study:
- To investigate the role of the Abcg5 gene mutation in DCM development.
- To explore the impact of phytosterols on cardiomyopathy progression.
- To characterize the inflammatory and cellular mechanisms underlying DCM in this mouse model.
Main Methods:
- Genetic analysis of A/J mice with the trac mutation.
- Histological and transmission electron microscopy (TEM) of cardiac tissue.
- Dietary intervention studies with phytosterol-free diets.
- Studies using B- and T-cell-deficient mice (Rag1 null).
Main Results:
- A/J-trac/trac mice developed progressive inflammatory and fibrosing cardiomyopathy.
- Lifelong phytosterol-free diets prevented DCM in A/J-trac/trac mice.
- BALB/cByJ-trac/trac mice showed delayed DCM onset and reduced T cell infiltrates with diet changes.
- B- and T-cell-deficient trac/trac mice did not develop inflammatory infiltrates or DCM.
Conclusions:
- The trac/trac mouse model exhibits features of inflammatory DCM.
- Dietary phytosterols are critical for DCM development in this model.
- Myocardial T cell infiltration is a key driver of DCM progression.
- This model offers a novel platform for studying inflammatory DCM and fibrosis reversibility.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

